Cermanova M - Search Results

1

Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.

Masin V, Blaha M, Stransky P, Blaha V, Cermanova M, Maly R, Zajic J. Masin V, et al. Among authors: cermanova m. Transfus Apher Sci. 2007 Feb;36(1):39-45. doi: 10.1016/j.transci.2006.10.004. Epub 2007 Feb 9. Transfus Apher Sci. 2007. PMID: 17292673

2

Optimization of the therapeutic procedure during LDL-apheresis--a computerized model.

Blaha M, Masin V, Stransky P, Blaha V, Cermanova M, Maly J, Belada D. Blaha M, et al. Among authors: cermanova m. Transfus Apher Sci. 2005 Apr;32(2):149-56. doi: 10.1016/j.transci.2004.10.022. Transfus Apher Sci. 2005. PMID: 15784449

3

Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia.

Bláha M, Cermanová M, Bláha V, Blazek M, Malý J, Siroký O, Solichová D, Filip S, Rehácek V. Bláha M, et al. Among authors: cermanova m. Ther Apher Dial. 2007 Feb;11(1):9-15. doi: 10.1111/j.1744-9987.2007.00450.x. Ther Apher Dial. 2007. PMID: 17309569

4

Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.

Blaha M, Cermanova M, Blaha V, Jarolim P, Andrys C, Blazek M, Maly J, Smolej L, Zajic J, Masin V, Zimova R, Rehacek V. Blaha M, et al. Among authors: cermanova m. Atherosclerosis. 2008 Mar;197(1):264-70. doi: 10.1016/j.atherosclerosis.2007.04.022. Epub 2007 May 30. Atherosclerosis. 2008. PMID: 17540382 Clinical Trial.

5

Fifteen years of single center experience with stem cell transplantation for multiple myeloma: a retrospective analysis.

Radocha J, Maisnar V, Zavrelová A, Cermanová M, Lánská M, Kmonícek M, Jebavý L, Bláha M, Malý J, Zák P. Radocha J, et al. Among authors: cermanova m. Acta Medica (Hradec Kralove). 2013;56(1):9-13. doi: 10.14712/18059694.2014.31. Acta Medica (Hradec Kralove). 2013. PMID: 23909048 Free article.

6

Prevention of infection transmission during stem cell transplantation.

Bláha M, Mericka P, Stepánová V, Splino M, Malý J, Jebavý L, Zák P, Cermanová M, Filip S, Blazek M, Rehácek V. Bláha M, et al. Among authors: cermanova m. Folia Microbiol (Praha). 2006;51(6):609-13. doi: 10.1007/BF02931627. Folia Microbiol (Praha). 2006. PMID: 17455799

7

Solitary extramedullary plasmacytoma in the oropharynx: advantages of intensity-modulated radiation therapy.

Vosmik M, Cermanova M, Odrazka K, Maisnar V, Zouhar M, Kordac P, Petera J. Vosmik M, et al. Among authors: cermanova m. Clin Lymphoma Myeloma. 2007 May;7(6):434-7. doi: 10.3816/CLM.2007.n.025. Clin Lymphoma Myeloma. 2007. PMID: 17621412

8

Management of severe infusion reactions after cetuximab.

Cerman J, Melichar B, Cermanova M, Solichova D. Cerman J, et al. Among authors: cermanova m. Acta Oncol. 2008;47(8):1609-11. doi: 10.1080/02841860802123204. Acta Oncol. 2008. PMID: 18607870 No abstract available.

9

Urinary neopterin in patients with advanced colorectal carcinoma.

Melichar B, Solichová D, Melicharová K, Malírová E, Cermanová M, Zadák Z. Melichar B, et al. Among authors: cermanova m. Int J Biol Markers. 2006 Jul-Sep;21(3):190-8. doi: 10.1177/172460080602100309. Int J Biol Markers. 2006. PMID: 17013802 Free article.

10

Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis.

Kost'ál M, Zák P, Vejrazková E, Cermanová M, Belohlávková P, Zavrelová A, Vrbacký F, Rozkos T, Nová M. Kost'ál M, et al. Among authors: cermanova m. Acta Medica (Hradec Kralove). 2012;55(3):142-5. doi: 10.14712/18059694.2015.53. Acta Medica (Hradec Kralove). 2012. PMID: 23297524 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page